Lv5
902 积分 2021-07-07 加入
Comparative Efficacy and Safety of Five Anti-calcitonin Gene-related Peptide Agents for Migraine Prevention A Network Meta-analysis
8小时前
已完结
Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trial
13小时前
已完结
Oral rimegepant for preventive treatment of migraine: a phase 2/3, randomised, double-blind, placebo-controlled trial
16小时前
已完结
Global epidemiology of migraine and its implications for public health and health policy
1天前
待确认
vidence-based guidelines for the pharmacological treatment of migraine
3天前
已完结
The American Headache Society Consensus Statement: Update on integrating new migraine treatments into clinical practice
3天前
已完结
Fremanezumab versus placebo for migraine prevention in patients with documented failure to up to four migraine preventive medication classes (FOCUS): a randomised, double-blind, placebo-controlled, phase 3b trial
7天前
已完结
Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of high-frequency episodic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase 2b study
7天前
已完结
Early treatment in migraine - A call to shift prevention from attacks to disease progression: A position statement from the International Headache Society
7天前
已关闭
Pharmacological management of migraine: current strategies and future directions
9天前
已完结
皖公网安备34019202002308
